Pregabid D 75/30 mg Capsule - Strip of 10

• Pregabid D 75/30 mg Capsule provides multidimensional pain relief by targeting both central and peripheral pain mechanisms.
• This formulation is effective in treating chronic neuropathic pain conditions such as diabetic peripheral neuropathy and fibromyalgia.
• Enhanced emotional well-being is achieved through Duloxetine's action on serotonin levels, helping to alleviate anxiety associated with chronic pain.
• Pregabid D 75/30 mg Capsule may reduce the need for opioid medications by effectively managing neuropathic pain.
• Patients often experience improved functional outcomes, including better mobility and sleep quality.
• The fixed-dose combination simplifies treatment regimens, making it easier for patients to adhere to their medication schedules.
• Many users report improved overall quality of life with fewer side effects compared to high-dose monotherapy.
• Pregabid D 75/30 mg Capsule is suitable for long-term use under medical supervision, providing sustained relief from chronic pain symptoms.

Pregabid D 75/30 mg Capsule combines two powerful medications: Pregabalin and Duloxetine. Pregabalin modulates calcium channel activity in nerve cells, while Duloxetine increases serotonin and norepinephrine levels to inhibit pain signals in the brain.

• Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, reducing excitatory neurotransmitter release.
• Duloxetine acts as a serotonin-norepinephrine reuptake inhibitor (SNRI), enhancing neurotransmitter levels that help regulate mood and pain perception.
• This combination effectively addresses both neuropathic pain and anxiety symptoms by targeting different mechanisms in the central nervous system.
• Pregabid D 75/30 mg Capsule helps improve pain thresholds while also enhancing emotional well-being.
• The dual action allows for a more comprehensive approach to managing chronic pain syndromes.

• Pregabid D 75/30 mg Capsule should be taken exactly as prescribed by a healthcare professional.
• The recommended dosage is typically once daily, preferably at the same time each day for consistency.
• This medication can be taken with or without food; however, taking it with food may help reduce stomach upset.
• Swallow the capsule whole with a glass of water; do not crush or chew the capsule.
• Maintaining consistent timing is crucial to preserve stable blood drug levels in the body.
• Do not abruptly stop taking Pregabid D 75/30 mg Capsule without consulting your doctor, as this may worsen symptoms or lead to withdrawal effects.
• Regular follow-up appointments with your healthcare provider are recommended to monitor progress and adjust dosage if necessary.

• Monitor mood and behavior closely while taking Pregabid D 75/30 mg Capsule; report any worsening depression or suicidal thoughts immediately.
• Rise slowly from sitting or lying positions to minimize dizziness caused by blood pressure changes.
• Adequate hydration and balanced nutrition can help mitigate side effects associated with this medication.
• Sun protection measures are recommended as some patients may experience photosensitivity while on this therapy.
• Regular monitoring of liver function tests may be advised during treatment with Pregabid D 75/30 mg Capsule.

• Common side effects of Pregabid D 75/30 mg Capsule include nausea, dizziness, fatigue, and dry mouth.
• Some patients may experience sleep disturbances or gastrointestinal issues such as constipation or diarrhea.
• Less common side effects may include blurred vision, weight changes, or mood alterations that require monitoring.
• Serious side effects that necessitate immediate medical attention include severe allergic reactions, suicidal thoughts, or signs of liver injury.
• Older adults or those with pre-existing liver or kidney conditions may be at higher risk for serious adverse reactions from Pregabid D 75/30 mg Capsule.

• Pregabid D 75/30 mg Capsule should not be used by individuals with known hypersensitivity to either Duloxetine or Pregabalin.
• Caution is advised when using this medication in patients with liver or kidney impairment; dose adjustments may be necessary.
• Alcohol consumption should be avoided while taking Pregabid D 75/30 mg Capsule due to increased risk of sedation and liver toxicity.
• Patients who are pregnant or breastfeeding should consult their healthcare provider before using this medication.
• This medication may impair driving ability; patients should avoid operating heavy machinery until they know how it affects them.